CAU Scholar's Space: Cho, Young Youn

Detailed Information

Cho, Young Youn (조영윤)

의과대학 (의학부(임상-서울))

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

hepatocellular carcinoma:12||Hepatocellular carcinoma:6||sorafenib:4||prognosis:4||Antiviral agents:3||chronic hepatitis B:3||survival:2||Kidney diseases:2||Hepatitis C virus:2||Liver cirrhosis:2||nonalcoholic fatty liver disease:2||hepatitis B surface antigen:2||Liver fibrosis:2||Acupuncture:2||Fatty liver:2||liver cancer:2||Metaanalysis:2||radiofrequency ablation:2||Transmission:2||Elasticity imaging techniques:2||Duodenum:1||Echoplanar imaging:1||Elastography:1||Embolization:1||Entecavir:1||Epidemiology:1||Gastrointestinal hemorrhage:1||Guanine:1||HBV:1||HBx:1||HCC:1||Health behavior:1||Hemophilia:1||Hepatitis B:1||Hepatitis B virus:1||Hepatitis B, chronic:1||Hepatitis C, chronic:1||Hepatocelluar carcinoma:1||Hepatocellular carcinoma (HCC):1||Hypoxia:1||Lifestyle:1||Logistic regressionbased method for significance analysis of multiple reaction monitoring (LRSAM):1||MESIAH:1||Mac2 binding protein glycosylation isomer:1||Magnetic resonance imaging:1||Membrane permeabilization:1||Metabolic syndrome:1||Metastasectomy:1||Multiple reactionmonitoring (MRM):1||Natural history:1||Neoplasms:1||Nonalcoholic fatty liver disease:1||Nonantidiabetic drugs:1||Nonalcoholic fatty liver disease:1||Overall survival:1||Peritoneal neoplasms/secondary:1||Prediction:1||Protein:1||Recurrence:1||Response:1||Risk factor:1||Risk factors:1||Risk stratification:1||Sorafenib:1||Sorafenib response:1||Suicidal thought:1||Surveillance interval:1||Survival:1||Survivors:1||TACE:1||Tenofovir alafenamide:1||The model to estimate survival in ambulatory hepatocellular carcinoma patients (MESIAH):1||Transarterial chemoembolization:1||Treatment:1||Ultrasonography:1||Varix:1||Viral hepatitis:1||acuteonchronic liver failure:1||antitumor activity:1||antiviral agents:1||antiviral therapy:1||antiviral treatment:1||biochemical recurrence:1||biochemical response:1||bleeding:1||bromopyruvate:1||chronic:1||comparison:1||entecavir:1||esophageal variceal ligation:1||esophageal varix:1||extrahepatic malignancy:1||fibrosis:1||good responder:1||hematopoietic stem cell transplantation:1||hepatic resection:1||hepatitis B:1||hepatitis B corerelated antigen:1||hepatitis B e antigen seroconversion:1||hepatitis B virus:1||hepatitis B virus X protein:1||hepatocellular:1||hexokinase inhibitor:1||immunotherapy:1||interleukin 28B:1||liver cirrhosis:1||liver fibrosis:1||locoregional therapy:1||membrane permeabilization:1||metaanalysis:1||multiple reaction monitoringmass spectrometry (MRMMS):1||neucleos(t)ide:1||nucleos(t)ide analog:1||percutaneous ethanol injection therapy:1||polymorphism:1||prevention:1||prognostic biomarker:1||prophylaxis:1||prostate cancer:1||proteomics:1||radical prostatectomy:1||reactivation:1||reactive oxygen speciesdependent activation:1||recurrence:1||relapse:1||resection:1||retreatment:1||spontaneous bacterial peritonitis:1||survivor:1||tenofovir:1||tenofovir alafenamide:1||tenofovir disoproxil fumarate:1||therapeutic:1||transarterial chemoembolization:1||transarterial therapy:1||tyrosine kinase inhibitor:1||ursodeoxycholic acid:1||validation:1||virologic response:1||virological suppression:1||3BP:1||viroporin:1||Acetazolamide:1||Apoptosis:1||Autonomic nervous system:1||Biomarker:1||Brainliver axis:1||Creactive protein:1||CLIFSOFA:1||COVID19 Infection:1||Cancer immunology:1||Carcinoma:1||Carcinoma, hepatocellular:1||Cardiolipin:1||Chemogenetics:1||Chronic hepatitis B:1||Chronic hepatitis C:1||Cirrhosis:1||Curative treatment:1||Depression:1||Diagnosis:1||

STATISTICS: Total View :6,849,344; Today View :3,605

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE